Currently, the management of diabetes primarily relies on lifestyle modifications and pharmacological interventions to maintain optimal blood glucose levels, thereby preventing or delaying the onset of diabetes-related complications (7, 8)
The timeline for visible results depends on several factors, including your starting point, age, overall health, and consistency with supplementation
About the study The current study performed a randomized, double-blind, crossover trial at the Research Institute of the McGill University Health Centre in Montreal, Quebec, Canada, to investigate whether semaglutide improved glycemic control and other nonglycemic outcomes in patients with T1D and using AID
Important to understand: semaglutide and tirzepatide aren't competitors in terms of safety